5 курс / Инфекционные болезни / Доп. материалы / Динамика_гуморального_и_Т_клеточного_иммунного_ответа
.pdfCoronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent
Patients // Clinical Infectious Diseases. 2020c. V. 71. № 10. P. 2688–2694. 154. Weiskopf D., Schmitz K.S., Raadsen M.P., Grifoni A., Okba N.M.A.,
Endeman H., Akker J.P.C. van den, Molenkamp R., Koopmans M.P.G., Gorp E.C.M. van, Haagmans B.L., Swart R.L. de, Sette A., Vries R.D. de. Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome // Science Immunology. 2020. V. 5. № 48.
155. Wen W., Su W., Tang H., Le W., Zhang X., Zheng Y., Liu X., Xie L., Li J., Ye J., Dong L., Cui X., Miao Y., Wang D., Dong J., Xiao C., Chen W., Wang H. Immune cell profiling of COVID-19 patients in the recovery stage by singlecell sequencing // Cell Discovery. 2020. V. 6. № 1. P. 31.
156.Wheatley A.K., Juno J.A., Wang J.J., Selva K.J., Reynaldi A., Tan H.-X., Lee W.S., Wragg K.M., Kelly H.G., Esterbauer R., Davis S.K., Kent H.E., Mordant F.L., Schlub T.E., Gordon D.L., Khoury D.S., Subbarao K., Cromer D., Gordon T.P., et al. Evolution of immune responses to SARS-CoV-2 in mildmoderate COVID-19 // Nature Communications. 2021. V. 12. № 1. P. 1162.
157.Wichmann D., Sperhake J.-P., Lütgehetmann M., Steurer S., Edler C., Heinemann A., Heinrich F., Mushumba H., Kniep I., Schröder A.S., Burdelski C., Heer G. de, Nierhaus A., Frings D., Pfefferle S., Becker H., BrederekeWiedling H., Weerth A. de, Paschen H.-R., et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 // Annals of Internal Medicine.
2020. V. 173. № 4. P. 268–277.
158.Wu D., Kolesnikov A., Yin R., Guest J.D., Gowthaman R., Shmelev A., Serdyuk Y., Dianov D. v., Efimov G.A., Pierce B.G., Mariuzza R.A. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors // Nature Communications. 2022. V. 13. №
1. P. 19.
159.Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
111
Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. // JAMA. 2020. V. 323. № 13. P. 1239–1242.
160. Yang Y., Yang M., Peng Y., Liang Y., Wei J., Xing L., Guo L., Li X., Li J., Wang J., Li M., Xu Z., Zhang M., Wang F., Shi Y., Yuan J., Liu Y. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection // Nature
Microbiology. 2022. V. 7. № 3. P. 423–433.
161. Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T., Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y., Li L., Li S. Molecular Architecture of the SARS-CoV-2 Virus // Cell. 2020. V. 183. №
3. P. 730738.e13.
162.Yaqinuddin A. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities // Medical Hypotheses. 2020. V. 144. P. 110049.
163.Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen // Nature. 2009. V. 458. № 7235. P. 211–214.
164.Zhao J., Yuan Q., Wang H., Liu W., Liao X., Su Y., Wang X., Yuan J., Li T., Li J., Qian S., Hong C., Wang F., Liu Y., Wang Z., He Q., Li Z., He B., Zhang T., et al. Antibody Responses to SARS-CoV-2 in Patients With Novel
Coronavirus Disease 2019 // Clinical Infectious Diseases. 2020. V. 71. № 16.
P. 2027–2034.
165.Zhao J., Zhao J., Perlman S. T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice // Journal of Virology. 2010. V. 84. №
18. P. 9318–9325.
166.Zhao Y., Nguyen P., Ma J., Wu T., Jones L.L., Pei D., Cheng C., Geiger T.L. Preferential Use of Public TCR during Autoimmune Encephalomyelitis //
The Journal of Immunology. 2016. V. 196. № 12. P. 4905–4914.
167. Zheng M., Gao Y., Wang G., Song G., Liu S., Sun D., Xu Y., Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients //
Cellular & Molecular Immunology. 2020. V. 17. № 5. P. 533–535.
112
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
168. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. A Novel Coronavirus from Patients with Pneumonia in China, 2019 // New
England Journal of Medicine. 2020. V. 382. № 8. P. 727–733.
169. Zinkernagel R.M., Hengartner H. Protective ‘immunity’ by pre existent neutralizing antibody titers and preactivated T cells but not by so called ‘immunological memory’ // Immunological Reviews. 2006. V. 211. № 1. P.
310–319.
170. Zvyagin I. v, Mamedov I.Z., Tatarinova O. v, Komech E.A., Kurnikova E.E., Boyakova E. v, Brilliantova V., Shelikhova L.N., Balashov D.N., Shugay M., Sycheva A.L., Kasatskaya S.A., Lebedev Y.B., Maschan A.A., Maschan M.A., Chudakov D.M. Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children //
Leukemia. 2017. V. 31. № 5. P. 1145–1153.
113